Status
Ongoing
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product for the treatment of male sexual enhancement, making this drug an unapproved drug.
Status
Ongoing
Classification
Class I
Report Date
February 28, 2024
Termination Date
—